Gabrielė Kulkovienė

Mrs. Gabrielė Kulkovienė

Lithuanian University of Health Sciences, Kaunas, Kauno Miestas, Lithuania
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
DPDeimantė Puzinovė
Deimantė Puzinovė
GKGabrielė Kulkovienė
Gabrielė Kulkovienė
JRJustina Rusteikaitė
Justina Rusteikaitė
RSRevathi Sampath
Revathi Sampath
ARAkvile Rudaityte
Akvile Rudaityte
Aiste JekabsoneAiste Jekabsone
Aiste Jekabsone
Each year, millions of individuals suffer from a non-healing wound, abnormal scarring, or injuries accompanied by an infection. For these cases, scientists are searching for new therapeutic interventions, from which one of the most promising is the use of extracellular vesicles (EVs). Naturally, EV-based signaling takes part in all four wound healing phases: hemostasis, inflammation, proliferation, and remodeling. Such an extensive involvement of EVs suggests exploiting their action to modulate the impaired healing phase. Furthermore, next to their natural wound healing capacity, EVs can be engineered for better defined pharmaceutical purposes, such as carrying specific cargo or targeting specific destinations by labelling them with certain surface proteins. This review aims to promote scientific awareness in basic and translational research of EVs by summarizing the current knowledge about their natural role in each stage of skin repair and the most recent findings in application areas, such as wound healing, skin regeneration, and treatment of dermal diseases, including the stem cell-derived, plant-derived, and engineered EVs.